XCath raised $30 million in a Series C round to support its endovascular robot.
- Amount
- $30M
- Stage
- Series C
- Announced
- 12 March 2026
- Leads
- Crescent Enterprises, Dr. Fred Moll
- Use of funds
- Bring endovascular robot to market and perform clinical telerobotic mechanical thrombectomy.
- Total raised
- $92M to date
- Checked
- Amount and date matched across 2 press sources